| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 4e-05 |